Verve Therapeutics
Jeff Meltzer is the vice president, of quality at Verve Therapeutics. Jeff has 25+ years of experience building successful teams, that implement effective GXP pharmaceutical Quality Management Systems. Prior to joining Verve, Jeff led the quality function for Affinia Therapeutics, Prevail Therapeutics, Trevena and PMRS. He has also worked at Bristol Myers Squibb and Alvogen. In these previous roles, he contributed to a broad range of INDs and commercial products. He obtained a Certified Pharmaceutical Industry Professional (CPIP) credential from ISPE and holds a BS and MS in industrial engineering from Lehigh University.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.